POLİKİSTİK OVER SENDROMU İLE TİROİT SAĞLIĞI İLİŞKİSİ: GELENEKSEL DERLEME

Year 2024, Volume: 3 Issue: 1, 36 - 48, 30.09.2024

Hacer Merve Fidan , Hilal Hızlı Güldemir , Indrani Kalkan

Abstract

Polikistik over sendromu (PKOS) üreme çağındaki kadınlarda yaygın olarak görülen bir endokrin sistem bozukluğudur. Polikistik over sendromunun yaygın semptomları arasında düzensiz menstrüasyon, hirşutizm, akne, alopesi, insülin direnci, fazla kilo ve ruh hali dalgalanlamaları bulunur. Polikistik over sendromu olan bireylerde glikoz metabolizmasında bozulmalar olabileceği, kan lipit profili ve tiroit parametrelerinin olumsuz seyredebileceği belirtilmektedir. Polikistik over sendromunda haşimato tiroiditine sık rastlanmasından oligo/ anovulasyona bağlı östrojen ve progesteron seviyelerindeki dengesizliğin sorumlu olabileceği varsayılmaktadır. Bununla birlikte tiroit ve PKOS’u birbirine bağlayan patofizyolojik yol tam olarak bilinmemektedir. Hipotiroidizm ve haşimato tiroiditi PKOS’ta en sık karşılaşılan tiroit bozukluklarındandır. Hipotiroidizm ve PKOS arasında obezite, insülin direnci, bozulmuş glikoz toleransı, dislipidemi ve insülin direnci gibi ortak semptomlar bulunur. Hipotiroidizmin cinsiyet hormonu bağlayıcı globülin (SHBG) seviyesini düşürerek PKOS’u kötüleştirdiği bilinmektedir. Polikistik over sendromunda subklinik hipotiroidizmin insülin direncini ve dislipidemiyi şiddetlendirdiği, normoglisemik bireylerde zaman içerisinde insülin direnci ve/ veya tip 2 diyabet gelişiminde etkili olabileceği ifade edilmektedir. Bu geleneksel derlemede PKOS ve tiroit sağlığı ilişkisinde etkili olan mekanizmalar ve bunlara bağlı gelişebilecek sorunlar araştırılmıştır.

Keywords

Hashimoto tiroiditi, hipotiroidizm, polikistik over sendromu, tiroit

RELATIONSHIP BETWEEN POLYCYSTIC OVARIAN SYNDROME AND THYROID HEALTH: A NARRATIVE REVIEW PCOS AND THYROID HEALTH

Abstract

Polycystic ovary syndrome (PCOS) is an endocrine system disorder common in women of reproductive age. Common symptoms of polycystic ovary syndrome include irregular menstruation, hirsutism, acne, alopecia, insulin resistance, excess weight, and mood swings. It is stated that in individuals with polycystic ovary syndrome, there may be disruptions in glucose metabolism, and blood lipid profile and thyroid parameters may be negative. It is assumed that the imbalance in estrogen and progesterone levels due to oligo/anovulation may be responsible for the frequent occurrence of Hashimoto's thyroiditis in polycystic ovary syndrome. However, the pathophysiological pathway connecting thyroid and PCOS is not fully known. Hypothyroidism and Hashimoto's thyroiditis are the most common thyroid disorders in PCOS. Common symptoms between hypothyroidism and PCOS include obesity, insulin resistance, impaired glucose tolerance, dyslipidemia, and insulin resistance. Hypothyroidism is known to worsen PCOS by decreasing the level of sex hormone binding globulin (SHBG). It is stated that subclinical hypothyroidism in polycystic ovary syndrome exacerbates insulin resistance and dyslipidemia, and may be effective in the development of insulin resistance and/or type 2 diabetes over time in normoglycemic individuals. In this traditional review, the mechanisms effective in the relationship between PCOS and thyroid health and the problems that may arise due to them were investigated.

Keywords

Hashimoto disease, hypothyroidism, polycystic ovary syndrome, thyroid gland

References

• Arduc, A., Aycicek Dogan, B., Bilmez, S., Imga Nasiroglu, N., Tuna, M. M., Isik, S., ... & Guler, S. (2015). High prevalence of Hashimoto’s thyroiditis in patients with polycystic ovary syndrome: does the imbalance between estradiol and progesterone play a role?. Endocrine research, 40(4), 204-210.
• Batóg, G., Dołoto, A., Bąk, E., Piątkowska-Chmiel, I., Krawiec, P., Pac-Kożuchowska, E., & Herbet, M. (2023). The interplay of oxidative stress and immune dysfunction in Hashimoto’s thyroiditis and polycystic ovary syndrome: a comprehensive review. Frontiers in Immunology, 14, 1211231.
• Bedaiwy, M. A., Abdel-Rahman, M. Y., Tan, J., AbdelHafez, F. F., Abdelkareem, A. O., Henry, D., ... & Liu, J. H. (2018). Clinical, hormonal, and metabolic parameters in women with subclinical hypothyroidism and polycystic ovary syndrome: a cross-sectional study. Journal of Women's Health, 27(5), 659-664.
• Chiofalo, B., Laganà, A. S., Palmara, V., Granese, R., Corrado, G., Mancini, E., ... & Triolo, O. (2017). Fasting as possible complementary approach for polycystic ovary syndrome: Hope or hype?. Medical hypotheses, 105, 1-3.
• de Medeiros, S. F., de Medeiros, M. A. S., Ormond, C. M., Barbosa, J. S., & Yamamoto, M. M. W. (2018). Subclinical hypothyroidism impact on the characteristics of patients with polycystic ovary syndrome. A meta-analysis of observational studies. Gynecologic and Obstetric Investigation, 83(2), 105-115.
• Escobar-Morreale, H. F. (2018). Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nature Reviews Endocrinology, 14(5), 270-284.
• Faghfoori, Z., Fazelian, S., Shadnoush, M., & Goodarzi, R. (2017). Nutritional management in women with polycystic ovary syndrome: A review study. Diabetes & metabolic syndrome: Clinical research & reviews, 11, S429-S432.
• Gawron, I. M., Baran, R., Derbisz, K., & Jach, R. (2022). Association of subclinical hypothyroidism with present and absent anti-thyroid antibodies with PCOS phenotypes and metabolic profile. Journal of Clinical Medicine, 11(6), 1547.
• Goyal, D., Relia, P., Sehra, A., Khandelwal, D., Dutta, D., Jain, D., & Kalra, S. (2019). Prevalence of hypothyroidism and thyroid autoimmunity in polycystic ovarian syndrome patients: A North Indian study. Thyroid Research and Practice, 16(2), 55-59.
• Ho, C. W., Chen, H. H., Hsieh, M. C., Chen, C. C., Hsu, S. P., Yip, H. T., & Kao, C. H. (2020). Hashimoto’s thyroiditis might increase polycystic ovary syndrome and associated comorbidities risks in Asia. Annals of Translational Medicine, 8(11).
• Ho, C. W., Chen, H. H., Hsieh, M. C., Chen, C. C., Hsu, S. P., Yip, H. T., & Kao, C. H. (2020). Increased risk of polycystic ovary syndrome and it’s comorbidities in women with autoimmune thyroid disease. International journal of environmental research and public health, 17(7), 2422.
• Hu, X., Chen, Y., Shen, Y., Zhou, S., Fei, W., Yang, Y., & Que, H. (2022). Correlation between Hashimoto’s thyroiditis and polycystic ovary syndrome: A systematic review and meta-analysis. Frontiers in Endocrinology, 13, 1025267.
• Kamrul-Hasan, A. B. M., Aalpona, F. T. Z., & Selim, S. (2020). Impact of Subclinical Hypothyroidism on Reproductive and Metabolic Parameters in Polycystic Ovary Syndrome–A Cross-sectional Study from Bangladesh. European Endocrinology, 16(2), 156.
• Karaköse, M., Hepsen, S., Çakal, E., Arslan, M. S., Tutal, E., Akın, Ş., ... & Özbek, M. (2017). Frequency of nodular goiter and autoimmune thyroid disease and association of these disorders with insulin resistance in polycystic ovary syndrome. Journal of the Turkish German Gynecological Association, 18(2), 85.
• Kowalczyk, K., Franik, G., Kowalczyk, D., Pluta, D., Blukacz, Ł., & Madej, P. (2017). Thyroid disorders in polycystic ovary syndrome. European Review for Medical & Pharmacological Sciences, 21(2), 346–360.
• Kowalczyk, K., Radosz, P., Barański, K., Pluta, D., Kowalczyk, D., Franik, G., & Madej, P. (2021). The influence of treated and untreated subclinical hypothyroidism on metabolic profile in women with polycystic ovary syndrome. International Journal of Endocrinology, 2021(1), 8427150.
• Lee, H. J., Jo, H. N., Noh, H. K., Kim, S. H., & Joo, J. K. (2023). Is there association between thyroid stimulating hormone levels and the four phenotypes in polycystic ovary syndrome?. Ginekologia Polska, 94(3), 203-210.
• Li, F., Lu, H., Huang, Y., Wang, X., Zhang, Q., Li, X., ... & Yang, Q. (2022). A systematic review and meta-analysis of the association between Hashimoto's thyroiditis and ovarian reserve. International Immunopharmacology, 108, 108670.
• Li, S., Chu, Q., Ma, J., Sun, Y., Tao, T., Huang, R., ... & Liu, W. (2017). Discovery of novel lipid profiles in PCOS: do insulin and androgen oppositely regulate bioactive lipid production?. The Journal of Clinical Endocrinology & Metabolism, 102(3), 810-821.
• Li, Y., Chen, C., Ma, Y., Xiao, J., Luo, G., Li, Y., & Wu, D. (2019). Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS). Life sciences, 228, 167-175.
• Macut, D., Bjekić-Macut, J., Rahelić, D., & Doknić, M. (2017). Insulin and the polycystic ovary syndrome. Diabetes research and clinical practice, 130, 163-170.
• Mancini, A., Bruno, C., Vergani, E., d’Abate, C., Giacchi, E., & Silvestrini, A. (2021). Oxidative stress and low-grade inflammation in polycystic ovary syndrome: controversies and new insights. International Journal of Molecular Sciences, 22(4), 1667.
• Mohammad, M. B., & Seghinsara, A. M. (2017). Polycystic ovary syndrome (PCOS), diagnostic criteria, and AMH. Asian Pacific journal of cancer prevention: APJCP, 18(1), 17.
• Nasri, K., Jamilian, M., Rahmani, E., Bahmani, F., Tajabadi-Ebrahimi, M., & Asemi, Z. (2018). The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. BMC endocrine disorders, 18, 1-8.
• Novais, J. D. S. M., Benetti-Pinto, C. L., Garmes, H. M., Menezes Jales, R., & Juliato, C. R. T. (2015). Polycystic ovary syndrome and chronic autoimmune thyroiditis. Gynecological Endocrinology, 31(1), 48-51.
• Pan, M., Zhang, J., Zhang, Q., Wang, F., Qu, F., & Jin, M. (2023). Association of serum thyroid hormone levels with androgen and metabolic parameters in chinese women with polycystic ovary syndrome: A retrospective cross-sectional study. Clinical and Experimental Obstetrics & Gynecology, 50(8), 162.
• Peddemul, A., Tejovath, S., Hassan, D., Patel, K. K., Sikandar, R., Kahlon, S. S., ... & Mostafa, J. A. (2022). Influence of subclinical hypothyroidism on women with polycystic ovary syndrome: a Literature Review. Cureus, 14(8).
• Raj, D., Pooja, F. N. U., Chhabria, P., Kalpana, F. N. U., Lohana, S., Lal, K., ... & Khalid, D. (2021). Frequency of subclinical hypothyroidism in women with polycystic ovary syndrome. Cureus, 13(9).
• Romitti, M., Fabris, V. C., Ziegelmann, P. K., Maia, A. L., & Spritzer, P. M. (2018). Association between PCOS and autoimmune thyroid disease: a systematic review and meta-analysis. Endocrine connections, 7(11), 1158-1167.
• Rosivari, P. S., Kalki, H., & Deekala, R. S. (2022). A study regarding the interrelation between subclinical hypothyroidism & insulin resistance among PCOS women. European Journal of Cardiovascular Medicine, 12(1).
• Serin, A. N., Birge, Ö., Uysal, A., Görar, S., & Tekeli, F. (2021). Hashimoto’s thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to Anti-Müllerian hormone levels. BMC Endocrine Disorders, 21, 1-8.
• Shaaban, Z., Khoradmehr, A., Shirazi, M. R. J., & Tamadon, A. (2019). Pathophysiological mechanisms of gonadotropins–and steroid hormones–related genes in etiology of polycystic ovary syndrome. Iranian journal of basic medical sciences, 22(1), 3.
• Shahid, R., Iahtisham-Ul-Haq, Mahnoor, Awan, K. A., Iqbal, M. J., Munir, H., & Saeed, I. (2022). Diet and lifestyle modifications for effective management of polycystic ovarian syndrome (PCOS). Journal of food biochemistry, 46(7), e14117.
• Singh, J., Wong, H., Ahluwalia, N., Go, R. M., & Guerrero-Go, M. A. (2020). Metabolic, hormonal, immunologic, and genetic factors associated with the incidence of thyroid disorders in polycystic ovarian syndrome patients. Cureus, 12(11).
• Singla, R., Gupta, Y., Khemani, M., & Aggarwal, S. (2015). Thyroid disorders and polycystic ovary syndrome: An emerging relationship. Indian journal of endocrinology and metabolism, 19(1), 25-29.
• Szczuko, M., Kikut, J., Szczuko, U., Szydłowska, I., Nawrocka-Rutkowska, J., Ziętek, M., ... & Saso, L. (2021). Nutrition strategy and life style in polycystic ovary syndrome—Narrative review. Nutrients, 13(7), 2452.
• Trakakis, E., Pergialiotis, V., Hatziagelaki, E., Panagopoulos, P., Salloum, I., & Papantoniou, N. (2017). Subclinical hypothyroidism does not influence the metabolic and hormonal profile of women with PCOS. Hormone Molecular Biology and Clinical Investigation, 31(3), 20160058.
• Wekker, V., Van Dammen, L., Koning, A., Heida, K. Y., Painter, R. C., Limpens, J., ... & Hoek, A. (2020). Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Human reproduction update, 26(6), 942-960.
• Yu, Q., & Wang, J. B. (2016). Subclinical hypothyroidism in PCOS: impact on presentation, insulin resistance, and cardiovascular risk. BioMed Research International, 2016(1), 2067087.
• Zhao, H., Zhang, Y., Ye, J., Wei, H., Huang, Z., Ning, X., & Fu, X. (2021). A comparative study on insulin secretion, insulin resistance and thyroid function in patients with polycystic ovary syndrome with and without Hashimoto’s thyroiditis. Diabetes, Metabolic Syndrome and Obesity, 1817-1821.